All amounts are reported in Canadian dollars and compared to the quarter ended September 30, 2023, unless otherwise stated. IM Cannabis Corp. ("IM Cannabis" or the "Company") (NASDAQ: IMCC ...

30, before financial markets open on Friday, Nov. 8, 2024. IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) a medical cannabis company with operations in Israel and Germany, will report operational ...

Analysts estimate that IM Cannabis will report an earnings per share (EPS) of $-0.39. The market awaits IM Cannabis's ...

IM Cannabis Corp (NASDAQ:IMCC) experienced extraordinary growth in the German market following partial legalization in April 2024. The company reduced operating expenses by 53% since 2022 ...

IM Cannabis Corp. (IMCC) came out with a quarterly loss of $ ... The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. Prestige Consumer Healthcare's revenues ...

Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...

IM Cannabis Corp (NASDAQ:IMCC) experienced extraordinary growth in the German market following partial legalization in April 2024. The company reduced operating expenses by 53% since 2022, with a ...

There are no SEC filings that match your filter(s), please update your selections to return more records. Nasdaq provides company’s SEC filings, which are financial statements and reports filed ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...